UK markets closed

Biogen Inc. (BIIB.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
3,290.000.00 (0.00%)
As of 01:43PM CST. Market open.
Full screen
Loading interactive chart…
  • Yahoo Finance Video

    Biogen stock rises on Q1 results, Alzheimer's drug sales

    Shares of the biopharmaceutical company Biogen (BIIB) are on the rise Wednesday, buoyed by the company's first quarter results. The company beat profit expectations, driven by Biogen's cost-cutting initiatives and the boost in sales for its Alzheimer's drug, Leqembi. Yahoo Finance's Anjalee Khemlani breaks down the details of the report. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith


    Biogen Stock Rises After Earnings, Jump in Sales of Alzheimer’s Drug

    Biogen stock moved higher after the biopharmaceutical company reported better-than-expected earnings and a hefty increase in sales of its Alzheimer’s drug. Biogen reported first-quarter adjusted earnings of $3.67 a share from revenue of $2.29 billion. Optimistic commentary from Biogen regarding its Alzheimer’s treatment Leqembi contributed to Wednesday’s gain.

  • Investor's Business Daily

    Biogen Stock Surges After Two Notable Products Walloped Sales Expectations

    Two of Biogen's newest drugs walloped first-quarter sales expectations on Wednesday, and helped Biogen stock jump.